December 2025

The year 2025 marked a strong revival in pharmaceutical mergers and acquisitions, as global drug makers moved firmly to strengthen pipelines, manage upcoming patent expiries, and secure sustainable growth. Several high-value and strategically important deals defined the year, reflecting renewed confidence in the sector. Major pharmaceutical companies pursued acquisitions not just for scale, but for access to late-stage assets, innovative technologies, and high-growth therapeutic areas.

Dr. Ruchi Sogarwal, a distinguished leader in public health and corporate affairs, Takeda Pharma, has been honoured with the Rajasthan WGA Award for Leadership in Corporates and recognised among the Top 10 Women Leaders in Business & Corporates. The award celebrates Rajasthan ki beti who have successfully broken barriers to reach leadership positions in national and global corporate leadership tables, inspiring the next generation of women leaders.

Anusandhan National Research Foundation (ANRF) announces call for proposals for the new scheme called J. C. Bose Grant, a restructured form of the J. C. Bose Fellowship running under erstwhile Science and Engineering Research Board (SERB). The J. C. Bose Grant is meant to recognize active, senior scientists and engineers within our country for their outstanding performance and contributions. The prestigious J. C. Bose Grant is individual-specific, very selective and encourages senior level researchers for extra-mural funding to further enhance their research in frontline avenues.